Coalition calls on Congress to repeal Biden's prescription drug price controls
More than 40 groups have signed onto a letter asking Congress to end the prescription drug price control scheme included in the Inflation Reduction Act.
NJ Democrat-turned-Republican considers challenging scandal-plagued Menendez: 'If I run, I'll beat him'
Rep. Jeff Van Drew, a Cape May Republican and former Democrat, said if he decides to run against Sen. Robert Menendez or for his seat, he will win.
Johnson & Johnson ditching script logo after 130 years
Johnson & Johnson announced that it's ditching the classic cursive script it has used for 130 years in favor of a revamped logo that pays homage to the old design.
Corporate diversity policies may face scrutiny after Supreme Court's affirmative action ruling
The Supreme Court's ruling rejecting the use of affirmative action and consideration of race as a factor in college admissions could prompt challenges to companies' diversity programs.
J&J consumer-health IPO process to kick off key test for moribund new-issue market
J&J’s consumer business makes Tylenol; Band-Aids and other wound-care products; baby-care products such as Johnson’s Baby Shampoo; and skin-care offerings such as Aveeno and Neutrogena.
DeSantis calls for Florida grand jury to investigate coronavirus vaccine 'wrongdoing'
Florida Gov. Ron DeSantis, during a panel about reported side effects of coronavirus vaccines, says he wants a statewide grand jury to investigate any "wrongdoing" surrounding them.
Queen Elizabeth II was a faithful steward of the US-UK 'special relationship': Former American ambassador
Former United States Ambassador to the United Kingdom Woody Johnson, owner of the New York Jets, reacted to the death of Queen Elizabeth II.
Opioid crisis: New Hampshire strikes $40.5 million settlement with Johnson & Johnson
New Hampshire Attorney General John Formella announced that the state reached a $40.5 million settlement with Johnson & Johnson over opioid claims on Thursday.
Johnson & Johnson to end sale of talc-based baby powder globally in 2023
Johnson & Johnson announced on Thursday that it will end global sales of talc-based baby powder and transition to an all cornstarch-based portfolio by 2023.
FDA puts new limits on Johnson & Johnson vaccine due to rare blood clotting condition
The FDA revised its emergency authorization to sharply limit the use of Johnson & Johnson's COVID-19 vaccine due to a rare but potentially fatal blood clotting condition called thrombosis with thrombocytopenia syndrome (TTS).